Search

everythinglearnresearchcommunity

for

Search:↓

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Liposomes can safely and effectively deliver substances to mouse hair follicles, potentially useful for human hair treatments.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

The document concludes that careful design of genetic fate mapping experiments is crucial for accurate cell lineage tracing in mice.

The scaffold improves wound healing and tissue regeneration.

Combining microsurgery with craniofacial reconstruction improves aesthetic results and reduces harm to the area where tissue is taken from.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Some drugs used to treat inflammation may cause hair loss.

Severe digestive issues in DRESS need early endoscopy for better treatment.

Free tissue transfer is highly effective for fixing exposed implants after skull surgery.

New Australian advertising rules improved stem cell marketing practices but further regulation is needed for consumer safety.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Rituximab can cause skin issues, but baricitinib may help improve them.

Patients in Australia underwent costly, unproven stem cell treatments due to weak regulations and aggressive marketing.

Nanozymes show promise for effective and safe cancer treatment.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Organoid technology is improving personalized medicine by better predicting drug responses and treatments.

Researchers created 10 new compounds similar to cercidin, which could lead to new antibiotics.

Using existing drugs for new treatments is cost-effective and safer.

Non-viral delivery systems and stimuli-responsive nanoformulations can improve CRISPR-Cas9 gene therapy.

Chitosan and melatonin together improve wound healing and have potential in medicine and cosmetics.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Chitosan nanoparticles loaded with Minoxidil were effective for hair growth but released the drug more slowly than the amphiphilic derivative.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Chitosan-based materials are promising for treating diseases and healing wounds due to their beneficial properties.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.